C/EBPβ, over-expressed via its hypomethylated enhancer, has emerged as a crucial regulator of HCC tumorigenicity through genome-wide enhancer and super-enhancer remodeling. This evidence concerns the gene CEBPB and hepatocellular carcinoma.